Melanoma Vaccine Triggers T-Cells to Attack Tumors
548735
MONDAY, Jan. 17 (HealthDayNews) -- Vaccines that contain tumor proteins help fight deadly melanoma skin cancer by increasing the number of immune system killer T-cells that can attack the tumor, says research in the Jan. 17 issue of the Journal of Experimental Medicine.
120543
Scientists say they may be able to make cancer drugs target tumours by using ultra-violet light to activate them.
42328
A leukemia vaccine has been successful enough in its first trials to warrant larger studies that will include hundreds of patients, researchers report.
333108
Washington - A vaccine may work to protect women against a virus that causes most cases of cervical cancer, US researchers reported on Monday.
277289
New data shows a vaccine against the virus that causes cervical cancer partially blocks infection by 10 strains of the virus on top of the four types the vaccine targets.
551343
Years of clinical trials have yielded promising results for a vaccine that would protect women from a virus that causes cervical cancer.
208514
Clinical trials of an experimental vaccine developed to protect women against a virus that causes cervical cancer have yielded promising results, according to reports.
224449
A team of scientists in Glasgow say they have devised a new method of attacking cancer cells.
4244
A protein that plays a critical role in the growth of the deadly skin cancer melanoma has been identified by scientists at Dana-Farber Cancer Institute and Children&#39;s Hospital Boston.
246130
WEDNESDAY, July 11 (HealthDay News) -- Changes in two genes that activate the immune system after tissue damage may increase lung cancer risk, researchers report.
43396
Scientists are one step closer to a vaccine against one of the world&#39;s most devastating diseases. Malaria causes more than 300 million cases of illness
488705
A new gene therapy causes the bladder to act like a &quot;bioreactor&quot; and secrete an anticancer agent that has proven to fight human tumors.
307115
GlaxoSmithKline Plc&#39;s experimental vaccine was effective against a virus that causes cervical cancer in a study, the first to show the treatment may provide protection against the No.
154293
TUESDAY, Feb. 19 (HealthDay News) -- Combining periodic infusions of antibodies with a widely used cancer vaccine appears to be more effective and less harsh with melanoma and advanced ovarian cancer patients than using either treatment on its own, a new study shows.
339519
An experimental vaccine against one strain of the human papilloma virus blocked most infections by the virus and, more important, prevented development of a precursor of cervical cancer caused by the virus, researchers said Monday.
561628
Researchers say a second experimental cervical-cancer vaccine appears to protect broadly against infection and risky precancerous conditions for more than two years, affirming scientists
75036
It's one of the most common cancers in  women and kills about a quarter of a million patients each year  but scientists said on Friday that a new vaccine could prevent  most cases of cervical cancer.